BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Acid-PEG3-NHS ester | Acid-PEG3-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. CAS No. 1835759-79-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-501559. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Acid-PEG3-PFP ester | Acid-PEG3-PFP ester is a polyethylene glycol (PEG)-based PROTAC linker. Acid-PEG3-PFP ester can be used in the synthesis of a series of PROTACs. Group: Pharmaceutical. CAS No. 1835759-67-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-501210. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG3-SS-PEG3-acid | Acid-PEG3-SS-PEG3-acid. Group: Pharmaceutical. CAS No. 2055014-98-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BADC-01037. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG3-SSPy | Acid-PEG3-SSPy is a polyethylene glycol (PEG)-based PROTAC linker. Acid-PEG3-SSPy can be used in the synthesis of a series of PROTACs. Group: Pharmaceutical. CAS No. 2088570-69-6. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-500500. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG4-mono-methyl ester | Acid-PEG4-mono-methyl ester is a polyethylene glycol (PEG)-based PROTAC linker. Acid-PEG4-mono-methyl ester can be used in the synthesis of a series of PROTACs. Group: Pharmaceutical. CAS No. 2028284-75-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-501165. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG4-NHS ester | Acid-PEG4-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-1036. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG4-S-PEG4-acid | Acid-PEG4-S-PEG4-acid is a polyethylene glycol (PEG)-based PROTAC linker. Acid-PEG4-S-PEG4-acid can be used in the synthesis of a series of PROTACs. Group: Pharmaceutical. CAS No. 2055041-21-7. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-501118. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG4-S-S-PEG4-acid | Acid-PEG4-SS-PEG4-acid is a homobifunctional cleavable linker with carboxylic acid groups at both sides. The terminal carboxylic acids can be reacted with primary amines in the presences of activators such as EDC and HATU to form stable amide bonds. The disulfide bonds can be cleaved by using Dithiothreitol (DTT) reagent. Group: Pharmaceutical. CAS No. 2055015-40-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-501142. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG5-Amide-Tri(3-methoxypropanamide-PEG4-Azide) Methane | Acid-PEG5-Amide-Tri(3-methoxypropanamide-PEG4-Azide) Methane. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: R14-0040. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG5-bis-PEG3-azide | A branched linker with two azides for click chemistry and a carboxylic acid. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: R14-0328. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG5-NHS ester | Acid-PEG5-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. CAS No. 1343476-41-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-501159. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG5-TEMPO | Acid-PEG5-TEMPO is a PEG linker with a terminal carboxylic acid and TEMPO moiety. The terminal carboxylic acid can react with primary amines in the presence of activators such as EDC and HATU to form stable amide bonds. The hydrophilic PEG linker increases the water solubility of the compound. TEMPO is a stable radical with applications in chemistry and biochemistry. It is used as a radical marker, a structural probe for biological systems in conjunction with electron spin resonance spectroscopy, a reagent in organic synthesis, and as a mediator in controlled radical polymerization. It is commonly used as a catalyst in organic chemistry synthesis for the oxidation of primary alcohols to aldehydes. Please contact us for GMP-grade inquiries. Group: Pharmaceutical. CAS No. 2055040-79-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-4126. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG6-NHS ester | Acid-PEG6-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-1031. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG7-NHS ester | Acid-PEG7-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-1028. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG8-NHS ester | Acid-PEG8-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-1030. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG8-t-butyl ester | Acid-PEG8-t-butyl ester. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-4149. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-PEG9-NHS ester | Acid-PEG9-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Group: Pharmaceutical. CAS No. 1895916-27-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BP-500446. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acid-propionylamino-Val-Cit-OH | Acid-propionylamino-Val-Cit-OH. Group: Pharmaceutical. CAS No. 2098907-84-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BADC-01058. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-IEPD-AFC | Ac-IEPD-AFC is a peptide whose sequence is preferred recognition motif for the serine protease granzyme B. It is a fluorogenic substrate. Group: Pharmaceutical. CAS No. 1135417-31-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-010421. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Ile-Glu-Pro-Asp-AMC | Ac-Ile-Glu-Pro-Asp-AMC is a preferred substrate sequence of granzyme B, which is a mammalian serine protease involved in the induction of rapid target cell death by cytotoxic lymphocytes. Group: Pharmaceutical. CAS No. 216757-33-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015136. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-ILE-TYR-GLY-GLU-PHE-NH2 | AC-ILE-TYR-GLY-GLU-PHE-NH2. Group: Pharmaceutical. CAS No. 168781-78-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015974. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acipimox-[13C2,15N2] | Acipimox-[13C2,15N2] is the labelled analogue of Acipimox, which is a niacin derivative used as a hypolipidemic agent. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-011765. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acipimox-[d4] | Labelled Acipimox. Acipimox (trade name Olbetam in Europe) is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as standard doses of nicotinic acid. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL cholesterol, which leads indirectly to a modest reduction in LDL and increase in HDL cholesterol. Group: Pharmaceutical. CAS No. 1246816-28-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003214. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acitretin-[d3] | Acitretin-d3 is a labelled Acitretin. Acitretin is a retinoid used for the treatment of psoriasis. Group: Pharmaceutical. CAS No. 1185241-03-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003528. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acitretin Impurities | Acitretin Impurities serve as crucial analytical markers in the biomedical sector, guiding the evaluation and enhancement of acitretin's quality, effectiveness, and safety profile. Primarily deployed in severe psoriasis management, their study aids in drug formulation refinement and potential side effect mitigation, thus safeguarding patient well-being. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acivicin | Acivicin is an isoxazole antibiotic isolated from Streptomyces. sviceus. Acivicin is a glutamine analog that irreversibly inhibits glutamine-dependent amidotransferases involved in nucleotide and amino acid biosynthesis (Kis = 10 and 560 μM for anthranilate synthase and glutamate synthase, respectively) as a potent antitumor antibiotic that induces apoptosis in human lymphoblastoid cells. Acivicin is an inhibitor of GGT used for solid tumor research. Uses: Protease inhibitor. Group: Pharmaceutical. CAS No. 42228-92-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00541. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclacinomycin | Aclacinomycin is an anthracycline drug that is used in the treatment of cancer. Group: Pharmaceutical. CAS No. 66676-88-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-05896. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclacinomycin B | Aclacinomycin B is an anthrone antitumor antibiotic isolated from Streptomyces galilaeus. Group: Pharmaceutical. CAS No. 57596-79-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00011. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclacinomycin Y | Aclacinomycin Y is an anthrone antitumor antibiotic isolated from Streptomyces galilaeus. Group: Pharmaceutical. CAS No. 66789-14-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00012. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclarubicin A | Aclarubicin is an oligosaccharide anthracycline antineoplastic antibiotic isolated from the bacterium Streptomyces galilaeus. It intercalates into DNA and interacts with topoisomerases I and II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. It is antagonistic to other agents that inhibit topoisomerase II, such as etoposide, teniposide and amsacrine. It has potent antineoplastic activity. It is used in the treatment of cancer. It can induce histone eviction from chromatin upon intercalation. It has been listed. Uses: Aclarubicin has potent antineoplastic activity. it is used in the treatment of cancer. it can induce histone eviction from chromatin upon intercalation. Group: Pharmaceutical. CAS No. 57576-44-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00542. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclarubicin hydrochloride | Aclarubicin is an oligosaccharide anthracycline antineoplastic antibiotic isolated from the bacterium Streptomyces galilaeus. Aclarubicin intercalates into DNA and interacts with topoisomerases I and II, thereby inhibiting replication and repair of DNA and RNA, and protein synthesis. Aclarubicin is antagonistic to other agents that inhibit topoisomerase II, such as etoposide, teniposide and amsacrine. This agent is less cardiotoxic than doxorubicin and daunorubicin. Uses: Antibiotics, antineoplastic. Group: Pharmaceutical. CAS No. 75443-99-1. Pack Sizes: 5 mg. Product ID: BBF-04081. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-LEHD-AFC | Ac-LEHD-AFC is a fluorogenic substrate for caspase-4, 5 and 9. Group: Pharmaceutical. CAS No. 210345-03-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015080. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclerastide | Aclerastide is an angiotensin receptor agonist, potentially used to treat tissue regeneration in diabetic ulcers and scars. Group: Pharmaceutical. CAS No. 227803-63-6. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-009063. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Leu-Arg-AMC | Ac-Leu-Arg-AMC is a fluorogenic peptide substrate. Group: Pharmaceutical. CAS No. 929621-79-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-009162. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-Leu-val-lys-aldehyde | AC-Leu-val-lys-aldehyde showed a stronger inhibition of cathepsin B (IC50 = 4 nM) than leupeptin (IC50 = 0.31 μM). Group: Pharmaceutical. CAS No. 147600-40-6. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015917. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclidinium Bromide-[d5] | Aclidinium Bromide-[d5] is a labelled analogue of Aclidinium Bromide. Aclidinium Bromide is a long-acting muscarinic antagonist (LAMA) used for the treatment of chronic obstructive pulmonary disease (COPD). Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003529. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclidinomycin A | Aclidinomycin A is a nalidixin antibiotic isolated from the Streptomyces halstedi. Aclidinomycin has anti-gram-positive bacteria and tumor activity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00013. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclidinomycin B | Aclidinomycin B is a nalidixin antibiotic isolated from the Streptomyces halstedi. Aclidinomycin has anti-gram-positive bacteria and tumor activity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00014. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclonifen-[d5] | A labelled analogue of Aclonifen, which is used as a pesticide and herbicide. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-009143. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aclonifen Impurities | Aclonifen Impurities, essential in the biomedical domain, are crucial for evaluating the purity and safety profiles of aclonifen. Their role aids in developing analytical methods for quantifying aclonifen residues, ensuring compliance with pharmacological standards, while propelling research to enhance therapeutic efficacy and reduce environmental impacts. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Lys-AMC | Ac-Lys-AMC, also known as MAL, is a fluorescent substrate for histone deacetylases (HDACs). Group: Pharmaceutical. CAS No. 156661-42-6. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015583. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Lys-D-Ala-D-Ala-OH | Ac-Lys-D-Ala-D-Ala-OH. Group: Pharmaceutical. CAS No. 28845-97-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-004917. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Lys-D-Ala-D-lactic acid acetate | Ac-Lys-D-Ala-D-lactic acid acetate. Group: Pharmaceutical. CAS No. 282729-62-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-014989. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Lys(Fmoc)-OH | Ac-Lys(Fmoc)-OH. Group: Pharmaceutical. CAS No. 148101-51-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015307. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Lys-Gln-Leu-Arg-AFC | Ac-Lys-Gln-Leu-Arg-AFC is the optimal substrate for human Hepsin, because KQLR/VVNG corresponds to its cleavage site. Excitation at 395-400 nm, emission at 495-505 nm. Hepsin is a membrane-anchored serine protease that is overexpressed in ovarian, prostate cancer and renal cell carcinomas, and therefore can be used as a prognostic marker. Group: Pharmaceutical. CAS No. 1802078-38-1. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-014545. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AcLys-PABC-VC-Aur0101 | AcLys-PABC-VC-Aur0101 is a cleavable anti-CXCR4 drug-linker conjugates for ADC. It has potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the cleavable linker AcLys-PABC-VC. Group: Pharmaceutical. CAS No. 1438851-17-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BADC-00596. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AcLys-PABC-VC-Aur0101 intermediate-1 | AcLys-PABC-VC-Aur0101 intermediate-1 is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. CAS No. 1609108-48-6. Pack Sizes: 1mg; 1g; 10g. Product ID: BADC-01741. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AcLysValCit-PABC-DMAE-SW-163D | AcLysValCit-PABC-DMAE-SW-163D is a drug-linker conjugates for ADC which consists of a natural bis-intercalator, SW-163D, conjugated via an AcLysValCitPABC-DMAE linker. Group: Pharmaceutical. CAS No. 2411007-69-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BADC-00869. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-MBP 1-11 | The major encephalitogenic epitope in myelin basic protein (MBP). Group: Pharmaceutical. CAS No. 125366-42-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-009163. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Nle-Pro-Nle-Asp-AMC | Ac-Nle-Pro-Nle-Asp-AMC is a substrate for proteasomes. It can be cleaved by the caspase-like site of proteasome, also known as postglutamyl peptide hydrolase (PGPH). AMC (7-amino-4-methylcoumarin) is released and produces the fluorescence utilized to quantify the caspase-like site activity. Ac-Nle-Pro-Nle-Asp-AMC also inhibits the chymotrypsin-like activity of the proteasome allosterically when bound to the caspase-like site. Group: Pharmaceutical. CAS No. 355140-49-7. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015113. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Octreotide | Ac-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. CAS No. 83795-61-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-014620. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aconine | Aconine is extracted form the roots of Aconitum kusnezoffii Reichb. Uses: A neurotoxin. Group: Pharmaceutical. CAS No. 509-20-6. Pack Sizes: 20 mg. Product ID: B0005-465425. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acoradiene, (-)-beta- | Acoradiene, (-)-beta-. Group: Pharmaceutical. CAS No. 28477-64-7. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-05118. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide | Acotiamide is a potent and seletive inhibitor of human and canine stomach-derived acetylcholinesterase (AChE). Acotiamide has been approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Uses: Cholinesterase inhibitors. Group: Pharmaceutical. CAS No. 185106-16-5. Pack Sizes: 100 mg. Product ID: B0084-284892. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide-[d4] | Labelled Acotiamide. Acotiamide is a potent and selective inhibitor of human and canine stomach-derived acetylcholinesterase (AChE). Acotiamide has been approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003215. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide-[d6] | Labelled Acotiamide. Acotiamide is a potent and selective inhibitor of human and canine stomach-derived acetylcholinesterase (AChE). Acotiamide has been approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003216. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide HCl | Acotiamide HCl is the hydrochloride salt of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. CAS No. 185104-11-4. Pack Sizes: 100 mg. Product ID: B0084-466105. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide Impurities | Acotiamide Impurities play a crucial role in the quality control and development of acotiamide, a drug used to treat functional dyspepsia. These impurities are essential for ensuring the safety and efficacy of acotiamide formulations, thereby supporting comprehensive pharmaceutical research and aiding in rigorous regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide impurity 1 | An analogue of ACOTIAMIDE. Group: Pharmaceutical. CAS No. 2150-55-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-008062. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide Impurity 5 | An impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. CAS No. 206882-15-7. Pack Sizes: 100 mg. Product ID: B0228-466100. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide Impurity 6 Maleate | An impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. CAS No. 185103-81-5. Pack Sizes: 100 mg. Product ID: B0228-466101. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide Impurity 9 | An impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. CAS No. 948053-83-6. Pack Sizes: 100 mg. Product ID: B0228-466104. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acotiamide Related Compound 12 | An impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. CAS No. 185105-98-0. Pack Sizes: 100 mg. Product ID: B0228-466118. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ACP | ACP. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BB075263. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ACP-5862 | ACP-5862 is a metabolite of Acalabrutinib, a second-generation BTK inhibitor used as a medication indicated for the treatment of non-Hodgkin lymphoma known as mantle cell lymphoma. Group: Pharmaceutical. CAS No. 2230757-47-6. Pack Sizes: 1 mg. Product ID: B2694-338759. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-PEG-AC, MW 600-35k | AC-PEG-AC has two activated acrylate terminal groups. Commonly used in the preparation of polyethylene glycol hydrogel. Homobifunctionalized PEG derivatives have wide applications in peptides, proteins, lipids, other small molecules and surface modifications. The PEG is a highly hydrophilic molecule containing a large amount of ethoxy groups, which causes high hydrodynamic volume in aqueous solution. commonly used in the preparation of polyethylene glycol hydrogel. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-0416. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-PEG-COOH, MW 1k-10k | AC-PEG-COOH has two different activated terminal groups, an acrylate and a carboxylic acid. Heterobifunctionalized PEG derivatives are used in cell culture, pharmaceutical research, drug delivery and release, nanotechnology and new materials. Heterobifunctional PEG can be attached to different molecules or materials to extend the richness of different molecular combinations. PEG modification can create a spatial barrier around the drug, reduce the enzymatic hydrolysis of the drug, avoid the rapid elimination of kidney metabolism, and allow the drug to be recognized by cells of the immune system. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-0644. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-PEG-NH2, MW 1k-10k | AC-PEG-NH2 is a linear heterobifunctionalized PEG derivative with an acrylate and an amine. Heterobifunctionalized PEG derivatives are used in cell culture, pharmaceutical research, drug delivery and release, nanotechnology and new materials. Heterobifunctional PEG can be attached to different molecules or materials to extend the richness of different molecular combinations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-0649. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-PEG-NH-Boc, MW 1k-10k | AC-PEG-NH-Boc has two different activated terminal groups, an acrylate and a Boc protected amine. Heterobifunctionalized PEG derivatives are used in cell culture, pharmaceutical research, drug delivery and release, nanotechnology and new materials. Heterobifunctional PEG can be attached to different molecules or materials to extend the richness of different molecular combinations. PEG modification can create a spatial barrier around the drug, reduce the enzymatic hydrolysis of the drug, avoid the rapid elimination of kidney metabolism, and allow the drug to be recognized by cells of the immune system. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-0654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AC-PEG-OH, MW 1k-10k | AC-PEG-OH with two different activated terminal groups, an acrylate and a hydroxyl, is used in cell culture, pharmaceutical research, drug delivery and release, nanotechnology and new materials. Heterobifunctional PEG can be attached to different molecules or materials to extend the richness of different molecular combinations. PEG modification can create a spatial barrier around the drug, reduce the enzymatic hydrolysis of the drug, avoid the rapid elimination of kidney metabolism, and allow the drug to be recognized by cells of the immune system. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-0659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.